Sharla Boehm earned a teaching degree from the University of California, Los Angeles, before she channeled her talent for math into computer programming. While working at the RAND Corporation, she ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Stop us ...

- UNILATERAL MTLE: Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy evaluation period (N=9), and 100% median disabling ...

UCB has signed a definitive agreement to acquire Neurona Therapeutics in a deal worth up to $1.15bn, adding the latter’s lead asset NRTX-1001 to its epilepsy portfolio. The deal value comprises an ...

Belgium's UCB has dipped its toe into the M&A waters once again with an agreement to buy US biotech Neurona Therapeutics and its cell therapy for epilepsy. The takeover – which, if completed, will be ...

Belgian pharma company UCB (UCBJY) on Friday announced an agreement to acquire Neurona Therapeutics, a U.S.-based developer of cell therapies for neuronal diseases, for a total consideration of up to ...

April 17 (Reuters) - Belgian biopharmaceutical group UCB (UCB.BR), opens new tab said on Friday it ‌will acquire U.S.-based Neurona Therapeutics for up to $1.15 billion in a deal that will strengthen ...

After a recent streak of buyouts by some of Big Pharma's serial acquirers, Belgium's UCB is getting in on the action with a Friday acquisition potentially worth more than $1 billion. Building on its ...

UCB agreed to buy Neurona Therapeutics for up to $1.15 billion, a deal that would add potential epilepsy drug NRTX-1001 to the Belgian company's portfolio. The agreement includes $650 million upfront ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...